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CASE REPORT
Occipital lymph node metastasis 
from nasopharyngeal carcinoma: a special case 
report and literature review
Jing Yang*†, Wei‑Xiong Xia†, Yan‑Qun Xiang, Xing Lv, Liang‑Ru Ke, Ya‑Hui Yu and Xiang Guo
Abstract 
Cervical lymph node metastasis is common in patients with nasopharyngeal carcinoma (NPC), but occipital lymph 
node metastasis in NPC patients has not yet been reported. In this case report, we describe an NPC patient with 
occipital lymph node metastasis. The clinical presentation, diagnostic procedure, treatment, and outcome of this case 
were presented, with a review of the related literature.
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Background
In South China, nasopharyngeal carcinoma (NPC) is 
a common head and neck cancer, with an incidence of 
15–50 per 100,000 people [1, 2]. It is often called “Can-
ton Tumor” because of the highest morbidity of NPC 
in Guangdong Province, China. More than 70% of 
NPC patients have already developed cervical lymph 
node metastasis at initial diagnosis [3, 4]. Based on the 
American Joint Committee on Cancer classification [5], 
the definition of the cervical levels is shown in Table  1. 
Cervical levels of NPC, from high to low incidence, are 
level II, level III, level V, level IV, supraclavicular region, 
level I, and level VI [3]. However, to our knowledge, 
metastasis to the occipital lymph node in NPC has not 
been reported. In this case report, we describe one NPC 
patient with occipital lymph node metastasis and discuss 
the treatment regimen. We also review related literature.
Case report
A 19-year-old man from Jiangxi Province, China, was 
admitted with the chief complaint of bilateral cervical 
masses for 3  months. The patient did not complain any 
of the following symptoms: fever, nose bleeding, obstruc-
tion, tinnitus, diplopia, or headache. He had no history of 
trauma, surgery, smoking, or drinking. Physical examina-
tion showed a neoplasm in the nasopharynx and several 
enlarged cervical lymph nodes of bilateral levels II–V; the 
largest one was 10 cm × 8 cm. In addition, an occipital 
lymph node of 2 cm × 2 cm was palpable, with medium 
firmness and clear edge. The laboratory results were nor-
mal except for the results of Epstein-Barr virus (EBV). 
EBV levels were abnormally elevated: EBV viral capsid 
antigen (VCA)-IgA, 1:640; EBV early antigen (EA)-IgA, 
1:40; and EBV-DNA, 8.82 × 105 copies/mL.
Biopsy of the nasopharyngeal neoplasm confirmed 
undifferentiated non-keratinizing carcinoma. Because 
of the possibility, though rare, of NPC-caused metas-
tasis in the occipital region, a fine-needle aspiration 
of the occipital lymph node was also performed. The 
pathologic report after hematoxylin and eosin (H and 
E) staining identified poorly differentiated carcinoma, 
which suggested metastasis from NPC (Fig.  1a). Immu-
nohistochemical analysis and in situ hybridization of the 
occipital lymph node further confirmed the presence of 
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EBV-encoded RNAs (EBERs), indicating EBERs expres-
sion in tumor cells (Fig. 1b).
Magnetic resonance imaging (MRI) of the nasopharynx 
and neck revealed that the tumor extended into the right 
parapharyngeal space, right carotid sheath, right medi-
cal pterygoid muscle, right pterygopalatine fossa, right 
cavernous sinus, and vast area of the skull base. Bilater-
ally enlarged retropharyngeal lymph nodes and cervical 
lymph nodes at level IIa, IIb, III, IV, Va, and Vb were also 
detected. An occipital lymph node of 18 mm ×  19 mm 
was detected by MRI (Fig.  2). Other radiographic stud-
ies, including chest radiography, abdominal sonography, 
and a bone scan, showed no distant metastasis. Accord-
ingly, the patient was diagnosed comprehensively as hav-
ing T4N3M0 stage IVb undifferentiated non-keratinizing 
NPC.
The patient received two cycles of neoadjuvant 
chemotherapy with cisplatin (80  mg/m2, day 1) and 
5-fluorouracil (4000  mg/m2, days 1–5), repeated every 
21 days. The patient also received two cycles of concur-
rent cisplatin (80 mg/m2, day 1), repeated every 21 days. 
Then, intensity-modulated radiation therapy (IMRT) was 
administered: a total dose of 70  Gy to the gross tumor 
volume (GTV), 66 Gy to involved cervical lymph nodes, 
64  Gy to the prophylactic radiation area of the primary 
lesion, and 58 Gy to bilateral cervical fields (all levels). An 
extra target volume (a total dose of 70 Gy) was given to 
the occipital lymph node, and an extra prophylactic dose 
of 58 Gy was given to the 5- to 10-mm surrounding area. 
All doses were given in 32 fractions, 5  days per week. 
The whole course of treatment was completed with no 
disruptions.
Follow-up after completion of radiotherapy showed 
that the primary lesion and lesions in the cervical 
lymph nodes and the occipital lymph node could still be 
detected by MRI; however, they were much smaller than 
the sizes before treatment. At 1-month follow-up, the pri-
mary lesion and lesions in cervical lymph nodes and the 
occipital lymph node had shrunk further. At 3-month fol-
low-up, no primary lesion or lesions in lymph nodes were 
detected (Fig. 3). However, 6 months after treatment, the 
patient returned with a mass of 40 mm × 45 mm in the 
middle of the sternum. Later, ultrasound-guided biopsy 
histologically confirmed undifferentiated carcinoma. 
Further examination of whole-body positron emission 
tomography/computed tomography revealed multiple 
fluorodeoxyglucose uptake, with foci in the sternum, 
left ilium, bilateral internal mammary lymph nodes, and 
spleen, all of which were considered metastases for the 
high standard uptake value. The nasopharynx and related 
regions remained well controlled without sign of recur-
rence. Other abnormal indexes were EBV VCA-IgA titer 
of 1:320, EBV EA-IgA titer of 1:20, and EBV-DNA load of 
5.51 ×  103 copies/mL. Thus, the latest diagnosis of this 
patient was multiple distant metastases after chemora-
diotherapy for NPC. Palliative chemotherapy was needed 
immediately in this situation, but the patient and his par-
ents refused further treatment and left. Long-term fol-
low-up is being continued.
Discussion
NPC is an aggressive disease that metastasizes to lymph 
nodes, mostly the cervical lymph nodes. In an analy-
sis of 924 NPC patients, Mao et  al. [6] sought to deter-
mine the pattern of cervical lymphatic metastases. In 
these patients, sentinel metastases were found in the 
retropharyngeal space and level II, followed by level III, 
level V, level IV, and supraclavicular area. Another sim-
ilar study of 779 patients by Chen et  al. [7] showed the 
rates of cervical lymphatic metastases in different lev-
els: the highest was 76.6% in the retropharyngeal space, 
Fig. 1 Representative images of pathologic slices from fine‑needle 
aspiration of the occipital lymph node (original magnification, ×40). 
a Hematoxylin and eosin (H and E) stained section shows diffused 
tumor cells displaying characteristics of nasopharyngeal carcinoma 
(NPC) cells. b Immunohistochemical analysis and in situ hybridization 
of the occipital lymph node shows the expression of Epstein‑Barr 
virus‑encoded RNAs (EBERs) in tumor cells
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followed by 64.1% in level IIb, 49.3% in level IIa, 23.6% 
in level III, 8.6% in level Va, 4.2% in level IV, 2.7% in level 
Vb, and 0.13% in level I. However, studies of NPC lym-
phatic metastasis did not reveal a lymphatic drainage 
pathway to the occipital region. One possible approach 
for occipital lymph node metastasis from NPC, based 
on topographic anatomy [8], was presumed as the naso-
pharynx  →  jugulodigastric lymph nodes  →  superior 
deep lateral cervical lymph nodes → deep lateral cervi-
cal lymph nodes → occipital lymph node (backflow). In 
the present case report, the patient had T4N3M0 NPC 
with lymphatic metastasis in almost all levels; therefore, 
the occipital region could presumably be involved from 
lymph backflow of communicating lymphatic drainage 
branches.
A remarkable feature of this case was the notably large 
bilateral cervical lymph nodes, which may have contrib-
uted to the occipital lymph node metastasis described 
above. The tumor of this patient was staged as N3 cat-
egory; the definition of the tumor in N3 category is 
“metastasis in a lymph node(s)  >6  cm and/or to supra-
clavicular fossa, the last stage of N category, suggest-
ing the worst prognosis among patients with lymphatic 
metastasis and a very high risk of distant metastasis.” [5] 
Fig. 2 Magnetic resonance (MR) imaging of the NPC patient before treatment. T1‑weighted axial MR images a without contrast, b with contrast, 
and c T2‑weighted axial MR image show an occipital lymph node (18 mm × 19 mm) with equal T1 signal, long or equal T2 signal, and obvious 
enhancement (arrows). T1‑weighted sagittal MR image d without contrast and e with contrast also show an enlarged lymph node with enhance‑
ment in subcutaneous tissue of the occiput (arrows)
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In this case, we suggested that not only the lymph node 
size or supraclavicular fossa metastasis but also uncom-
mon regions such as the occipital lymph node was asso-
ciated with a high risk of distant metastasis. On the other 
hand, MRI scans of lymph nodes in the neck and occipi-
talia showed similarities, including approximate T1- and 
T2-weighted signals, the same liquefactive necrosis 
signs, and semblable lymphatic fusion. These imaging 
characteristics suggested that the occipital lymph node 
is very large and identical to the cervical metastatic 
lymph nodes. Pathologic confirmation indicated that 
the origin of the occipital lymph node metastasis was 
Fig. 3 MR imaging of the NPC patient at 3 months after treatment. T1‑weighted axial MR image of the nasopharynx a without contrast, b with 
contrast, and c T2‑weighted axial MR image of the nasopharynx show edema signal of the nasopharyngeal mucosa but no mass. T1‑weighted axial 
MR image d with contrast of previous occipital lymph node level and e T2‑weighted axial MR image of previous occipital lymph node level show 
normal structure now. T1‑weighted sagittal MR images f without contrast and g with contrast reveal no mass as well
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EBER-positive. It is well known that EBV plays an impor-
tant role in tumorigenesis and development of NPC 
and has been shown to be a biomarker of NPC [9–12]. 
Considering these results, we postulate that extensive 
cervical lymphatic metastasis, especially those meet-
ing the criteria of N3 category, could sporadically cause 
lymphadenectasis in unusual sites, which we hypoth-
esized as the medium transition between local metasta-
sis and distant metastasis. Lymphadenectasis in unusual 
sites likely tremendously increases the risk of systemic 
metastasis. Therefore, for patients who have N3 category 
tumors, physicians should be aware of unconventional 
lymphatic metastases, such as metastasis to the occipi-
tal lymph node. Once an unusual indication is detected, 
more extensive analyses should be performed until a final 
diagnosis is reached.
Metastasis to the occipital lymph node is uncommon. 
It occasionally occurs in cases of skin cancer or malig-
nancies of the cutaneous appendages of the head and 
neck, scalp lipoma or liposarcoma, scalp inflammation, 
lymphoma, malignancies of the external auditory canal, 
and melanoma of the head and neck. Other rare cases of 
occipital lymph node metastasis have been seen in sweat 
gland tumor [13, 14], lung cancer [15, 16], and thyroid 
cancer [17, 18]. Various treatment strategies for occipi-
tal lymph node metastases from cancers other than NPC 
are shown in Table  2. In a thyroid papillary carcinoma 
case, reported by Lin et al. [17] in 1997, the primary thy-
roid papillary carcinoma and the occipital metastatic 
mass were resected. Without further chemotherapy or 
radiotherapy, the patient died 17  months later due to 
seizures caused by metastasis to the brain [17]. The case 
showed that, although surgery could remove the occipital 
metastasis, distant metastasis would be a fatal failure. A 
case reported by Sheth et  al. [14] from Memorial Sloan 
Kettering Cancer Center demonstrated another poten-
tially effective multidisciplinary therapy for occipital 
metastasis. In this case of mucinous eccrine carcinoma, 
excision was performed and radiation was administered 
sequentially to the occipital area and lymph nodes, result-
ing in 4  years of disease-free survival. Later, two crani-
otomies and two courses of radiation to the brain and 
centrums helped the patient live an additional 4  years, 
after which the disease recurred [14]. This long-term 
survival was encouraging, reminding us that a promis-
ing outcome can be achieved in rare cases of occipital 
metastasis from different malignancies. The comprehen-
sive method used in common metastases, and multidisci-
plinary management including surgery and radiotherapy 
might be effective.
It is well known that radiotherapy is the principal treat-
ment of NPC. Currently, IMRT is widely used because it 
can maximize the radiation dose to the target and mini-
mize exposure to surrounding critical structures [19], 
simultaneously increasing the locoregional control rate 
and decreasing serious adverse effects [20]. In our case, 
IMRT was administered to the primary lesion, the cervi-
cal lymph nodes, and the pathologically confirmed occip-
ital lymph node. The same 70-Gy dose was administered 
to both the nasopharyngeal neoplasm and the occipital 
Table 2 Occipital lymph node metastases from different diseases
F female; M male; Y years
Authors/year Sex/age Primary disease Histology Treatment Result







Tian et al. [13]/1992 M/22Y Sweat gland tumor Syringocarcinoma Resection Died
Tian et al. [13]/1992 M/26Y Absent Melanoma Resection Survived (follow‑up, 
115 months)
He et al. [15]/1996 F/53Y Lung cancer Squamous cell carcinoma Treatment refusal Absent
Lin et al. [17] /1997 F/75Y Thyroid cancer Thyroid papillary microcar‑
cinoma
Resection Died after 17 months of treat‑
ment
Sheth et al. [14]/2010 F/45Y Sweat gland tumor Mucinous eccrine carcinoma Chemotherapy + radio‑
therapy
Died 8 years after the first 
treatment
Kamper et al. [16]/2011 F/69Y Lung cancer Bronchial carcinoma Chemotherapy + radio‑
therapy
Absent
Karabeir et al. [18]/2011 F/82Y Thyroid cancer Thyroid follicular carcinoma Absent Absent
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lymph node and resulted in a good local regional con-
trol so far, indicating that a standard IMRT dose could 
achieve satisfying local control; however, in this special 
case of unconventional lymphatic metastasis of NPC, 
radiation therapy alone was not enough to prevent dis-
tant metastasis. Recently, it was reported that simultane-
ous integrated boost-intensity modulated radiotherapy 
(SIB-IMRT) for patients with pediatric and adolescent 
NPC was an optional treatment. In the study by Tao et al. 
[21], 34 patients (age 8–20  years) received SIB-IMRT 
combined with chemotherapy; the results showed that 
this combination treatment could achieve excellent long-
term locoregional control with mild incidence of late 
toxicities. In these cases, distant metastasis was the pri-
mary cause of failure [21], which was consistent with the 
result of the present case study. On the other hand, as a 
systemic cure, chemotherapy combined with radiother-
apy plays an important role in the treatment of locally 
advanced NPC. In the case presented here, neoadjuvant 
chemotherapy followed by concurrent chemoradiother-
apy was disappointing in terms of systemic control, since 
multiple distant metastases occurred in a short time 
(6 months). Perhaps more aggressive chemotherapy, such 
as adjuvant chemotherapy, should be given in cases of 
uncommon lymphadenectasis like occipital lymph node 
metastasis. Besides radiotherapy and chemotherapy, tar-
geted therapy could be another option. In 2005, Chan 
et al. [22] launched a multicenter phase II study to inves-
tigate whether cetuximab in combination with chemo-
therapy could benefit NPC patients with recurrence or 
metastasis. The results were promising: the disease con-
trol rate of cetuximab in combination with chemotherapy 
was 60%, and adverse effects were acceptable.
Conclusions
Although occipital lymph node metastasis is rare in NPC, 
it may present in patients with extensive cervical lymph 
node involvement. Aggressive treatment with combined 
IMRT and chemotherapy might be beneficial in these 
cases. In radiotherapy such as IMRT, the occipital lymph 
node could be treated as another GTV with radical radia-
tion dose. Distant metastasis remains the primary cause 
of treatment failure. The proper treatment intensity of 
chemotherapy is unclear in this context; however, multi-
disciplinary medical management seems necessary. This 
special case is still open for discussion and comprehen-
sive study.
Abbreviations
AJCC: American Joint Committee on Cancer; EA: early antigen; EBER: Epstein‑
Barr virus encoded RNA; EBV: Epstein‑Barr virus; GTV: gross tumor volume; 
FDG: fluorodeoxyglucose; H and E: hematoxylin and eosin; IMRT: intensity‑
modulated radiation therapy; MRI: magnetic resonance imaging; PET/CT: 
positron emission tomography/computed tomography; NPC: nasopharyngeal 
carcinoma; SUV: standard uptake value; VCA: viral capsid antigen.
Authors’ contributions
JY collected the data and drafted the manuscript. YQX designed the study and 
helped revise the manuscript. GX conceived the study and participated in its 
coordination. XL, WXX, LRK, and YHY participated in the data interpretation. All 
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 17 August 2015   Accepted: 6 December 2015
References
 1. Cao SM, Xu YJ, Lin GZ, Huang QH, Wei KR, Xie SH, et al. Estimation of 
cancer burden in Guangdong Province, China in 2009. Chin J Cancer. 
2015;34(3):58.
 2. Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyn‑
geal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 
2014;33(8):381–7.
 3. Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional lymph 
node metastasis of nasopharyngeal carcinoma: a meta‑analysis of clinical 
evidence. BMC Cancer. 2012;12(1):98.
 4. Lv J, Wang R, Qing Y, Du Q, Zhang T. Magnetic resonance imaging 
analysis of regional lymph node metastasis in 1298 cases of naso‑
pharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 
2012;26(18):769–72 (in Chinese).
 5. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer 
staging manual. New York: Springer; 2010.
 6. Mao YP, Liang SB, Liu LZ, Chen Y, Sun Y, Tang LL, et al. The N staging 
system in nasopharyngeal carcinoma with radiation therapy oncology 
group guidelines for lymph node levels based on magnetic resonance 
imaging. Clin Cancer Res. 2008;14(22):7497–503.
 7. Chen QS, Lin SJ, Pan JJ, Zhang Y, Lin J, Chen Y, et al. The patterns of 
metastatic cervical nodes in 779 cases of nasopharyngeal carcinoma. 
Zhongguo Ai Zheng Za Zhi. 2010;20(1):50–4.
 8. Peng YW, Wang HJ, Yang HJ, Liu SW, Hu HT, Bo CZ. Topographic anatomy. 
5th ed. Beijing: Ren Min Wei Sheng Publishing House; 2001.
 9. Lun SW, Cheung ST, Lo KW. Cancer stem‑like cells in Epstein‑
barr virus‑associated nasopharyngeal carcinoma. Chin J Cancer. 
2014;33(11):529–38.
 10. Young LS, Dawson CW. Epstein‑barr virus and nasopharyngeal carci‑
noma. Chin J Cancer. 2014;33(12):581–90.
 11. Lung ML, Cheung AKL, Ko JMY, Lung HL, Cheng Y, Dai W. The interplay 
of host genetic factors and Epstein‑barr virus in the development of 
nasopharyngeal carcinoma. Chin J Cancer. 2014;33(11):556–68.
 12. Chan K. Plasma Epstein‑barr virus DNA as a biomarker for nasopharyn‑
geal carcinoma. Chin J Cancer. 2014;33(12):598–603.
 13. Tian AL, Wang HS. Clinical application of posterolateral neck dissection. 
Zhong Liu. 1992;05:216–9.
 14. Sheth RN, Placantonakis DG, Gutin PH. Intracranial and spinal metas‑
tases from eccrine mucinous carcinoma: case report. Neurosurgery. 
2010;67(3):E861–2.
 15. He DH, Li SX, Zhang CX, Zhao M. A case report of occipital lymph 
node metastasis from lung cancer. Zhong Liu Ji Chu Yu Lin Chuang. 
1996;03:175.
 16. Kamper L, Piroth W, Haage P. Subcutaneous mass as initial manifestation 
of an osteolytic metastasis. Dtsch Med Wochenschr. 2011;136(40):2040–2.
 17. Lin K, Lin J, Huang H, Jeng L, Ho Y. Skull metastasis with brain inva‑
sion from thyroid papillary microcarcinoma. J Formos Med Assoc. 
1997;96(4):280–2.
 18. Karabekir H, Polat C, Aktepe F, Gocmen‑Mas N. Unusual scalp metastasis 
from follicular thyroid carcinoma. Saudi Med J. 2011;32(8):849–51.
 19. Kristensen CA, Kjaer‑Kristoffersen F, Sapru W, Berthelsen AK, Loft A, Specht 
L. Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D 
conformal radiotherapy. Acta Oncol. 2007;46(2):214–20.
 20. Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation 
therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J 
Cancer. 2001;96(2):126–31.
Page 8 of 8Yang et al. Chin J Cancer  (2016) 35:1 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 21. Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li WF, et al. Long‑term outcome 
and late toxicities of simultaneous integrated boost‑intensity modulated 
radiotherapy in pediatric and adolescent nasopharyngeal carcinoma. 
Chin J Cancer. 2013;32(10):525–32.
 22. Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ, et al. Multicenter, 
phase II study of cetuximab in combination with carboplatin in patients 
with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol. 
2005;23(15):3568–76.
